Liver X Receptor Agonist Ups Glioblastoma Cell Death

LXR agonists inhibit LDL receptor upregulation, promote cholesterol efflux transporter

FRIDAY, Sept. 16 (HealthDay News) -- Liver X receptor (LXR) agonists cause inducible degrader of low-density lipoprotein receptor (LDLR)(IDOL)-mediated LDLR degradation and elevated expression of the ABCA1 cholesterol efflux transporter, which promotes cell death in a glioblastoma model, according to an experimental study published online Sept. 15 in Cancer Discovery.

Deliang Guo, Ph.D., from the Ohio State University Medical School in Columbus, and colleagues explored the role of cholesterol metabolism in glioblastoma pathogenesis, its association with epidermal growth factor receptor (EGFR)/phosphoinositide 3-kinase (PI3K) signaling, and its possible therapeutic application. Studies were conducted on glioblastoma cell lines, xenograft models, and clinical samples, including those from patients treated with lapatinib, an EGFR tyrosine kinase inhibitor.

The investigators identified an EGFR mutation (EGFRvIII)-activated, PI3K/sterol regulatory element-binding protein 1 (SREBP-1)-dependent tumor survival pathway through the LDLR. The LXR agonist GW3965 targeted LDLR, resulting in IDOL-mediated LDLR degradation and raised expression of the ABCA1 cholesterol efflux transporter. These mechanisms promoted tumor cell death in an in vivo glioblastoma model.

"This study reveals that glioblastoma cells have devised a mechanism to subvert the normal pathways for feedback inhibition of cholesterol homeostasis via EGFRvIII and PI3K-dependent activation of SREBP-1," the authors write.

One of the study authors disclosed financial ties to the pharmaceutical and biopharmaceutical industries.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events